Certificate products questioned Red pharmaceutical denies untrue content

Securities Times reporter Li Taizhou in response to the recent market emergence of Red Pharmaceutical (002550) CEP certificate and product quality problems, the silence for a period of time the red Pharmaceutical officially responded today. Company quality Director, Dong Secretary Fan in an interview, said, "Red Pharmaceutical publicly disclosed prospectuses related to CEP certificate and product quality statement no false untrue content." "Previously, according to media reports, the red pharmaceutical in the prospectus fictitious the company to obtain the EU CEP certificate information, which means that for the EU pharmaceutical market, the red pharmaceutical companies are not pharmaceutical enterprises, so it is described in the prospectus of the many facts and advantages do not set.　　In addition, because of quality problems, the red pharmaceutical heparin products were in 2008 by the German pharmaceutical regulatory authorities to recall the request, which is also deliberately concealed in its prospectus. Public data show that the red Pharmaceutical in July 2003 for the first time commissioned by the German helm company to apply for EU COS certification (European Pharmacopoeia Applicability certification), the European Drug Quality Administration (EDQM) officially issued a Heparin Sodium API CEP certificate.　　After the successful adoption of thousand Red Pharmaceutical certification, EDQM recently issued CEP certificate number "R1-cep 2002-012-rev 01" of the Heparin Sodium API CEP certificate. For the above query, Fan said, "This CEP certificate holder is the Red pharmaceutical commissioned by the German helm company, Certificate of certified products are red Pharmaceutical in Changzhou, Jiangsu, China factory production of heparin sodium raw materials products." The most important role of the CEP certificate is to prove that the manufacturer's products meet the requirements of the European Pharmacopoeia in the process system and product quality. In this way, Red Pharmaceutical opened the door to the European export products, and with a group of internationally renowned European pharmaceutical manufacturers, such as Mountain, Austrian Glass Christian, helm company established a long-term and stable customer relations. "And for 2008 years of product quality events, Red Pharmaceutical said that the relevant enterprises and regulatory authorities have ruled out the red pharmaceutical heparin ingredients contaminated suspicion, red pharmaceutical products do not exist in the corresponding quality problems." In early March 2008, the Wall Street Journal reported that a document issued by the Ministry of Health in Schleswig-Holstein, Germany, said three of the active ingredients used in the country's recall of heparin were produced by China's Changzhou thousand-Red Biochemical Pharmaceutical Co., Ltd. and a company. But at the end of the month, the Wall Street Journal again reported that the head of the Foreign Enterprise Quality Management Department, which had been recalled heparin, had checked the ingredients of the recalled heparin and ruled out the suspicion that the ingredients of the red pharmaceutical heparin were contaminated. The results have also been approved by the German official drug control laboratory.